F I Ershov Selected Research

Hepatitis

1/2015	[Usage of interferon inducers during viral infections].
1/2014	[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers].
1/2001	[Etiotropic therapy of the most widespread viral infections].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F I Ershov Research Topics

Disease

12	Human Influenza (Influenza) 01/2021 - 09/2000
11	Infections 01/2021 - 01/2000
10	Virus Diseases (Viral Diseases) 01/2021 - 05/2000
3	Hepatitis 01/2015 - 01/2001
3	Tuberculosis (Tuberculoses) 01/2014 - 01/2013
3	Communicable Diseases (Infectious Diseases) 01/2008 - 05/2000
2	COVID-19 01/2022 - 01/2021
2	Coronavirus Infections 01/2022 - 01/2021
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2016 - 01/2004
2	Herpes Genitalis (Genital Herpes) 01/2015 - 11/2003
2	Brucellosis (Malta Fever) 01/2014 - 01/2013
2	HIV Infections (HIV Infection) 01/2013 - 01/2001
2	Chronic Hepatitis C 01/2013 - 01/2013
2	Pyelonephritis 01/2011 - 01/2010
2	Herpetic Keratitis 01/2001 - 01/2000
1	Viral Pneumonia 01/2021
1	Fever (Fevers) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2020
1	Keratoconjunctivitis 01/2019
1	Eye Infections 01/2019
1	Coinfection 01/2015
1	Encephalitis (Encephalitis, Rasmussen) 01/2015
1	Herpes Simplex 01/2015
1	Rabies (Hydrophobia) 01/2015
1	West Nile Fever 01/2013
1	Viremia 01/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Pathologic Processes 01/2011
1	Kidney Diseases (Kidney Disease) 01/2010
1	Disease Progression 01/2010
1	Rheumatic Diseases (Rheumatism) 01/2010
1	Neurasthenia 01/2008
1	Anxiety Disorders (Anxiety Disorder) 01/2008
1	Leukoplakia 12/2004
1	Leukemia 01/2004
1	Hepatitis C 01/2002
1	Multiple Sclerosis 04/2001
1	Hepatitis A (Hepatitis, Infectious) 02/2001
1	Hepatitis B 02/2001
1	Viral Encephalitis 02/2001
1	Inflammation (Inflammations) 01/2000
1	Conjunctivitis 01/2000

Drug/Important Bio-Agent (IBA)

14	InterferonsIBA 01/2022 - 01/2000
8	CytokinesIBA 01/2019 - 01/2002
8	10-carboxymethyl-9-acridanoneIBA 01/2014 - 01/2000
7	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2001
4	Pharmaceutical PreparationsIBA 11/2020 - 09/2000
4	Interferon InducersIBA 01/2015 - 01/2010
3	Immunologic Factors (Immunomodulators)IBA 01/2013 - 01/2003
2	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 04/2001
2	AntigensIBA 01/2020 - 12/2004
2	Meglumine FDA Link 01/2014 - 01/2013
2	TP 7IBA 09/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 01/2003 - 11/2002
1	Biological ProductsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2020
1	Interferon beta-1a FDA Link 01/2015
1	Phosphates (Orthophosphate)IBA 01/2015
1	Interferon-betaIBA 01/2015
1	AntibodiesIBA 01/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	Keratin-17 (Keratin 17)IBA 12/2004
1	AcridinesIBA 01/2004
1	Antiparasitic Agents (Antiparasitics)IBA 01/2004
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2003
1	Interferon-alpha (Interferon Alfa)IBA 04/2001
1	larifanIBA 02/2001
1	Tilorone (Tilorone Hydrochloride)IBA 02/2001
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2001
1	poludanIBA 01/2000

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2000
1	Patient Admission (Patient Admissions) 01/2022
1	Length of Stay 01/2021
1	Local Anesthesia 01/2019
1	Immunomodulation 01/2010
1	Aftercare (After-Treatment) 11/2003
1	Immunotherapy 04/2001